28534-1-AP
antibody from Proteintech Group
Targeting: PRKDC
DNA-PKC, DNA-PKcs, DNAPK, DNAPKc, DNPK1, HYRC, HYRC1, p350, p460, XRCC7
Antibody data
- Antibody Data
- Antigen structure
- References [4]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 28534-1-AP - Provider product page

- Provider
- Proteintech Group
- Product name
- PRKDC antibody
- Antibody type
- Polyclonal
- Description
- PRKDC antibody (Cat. #28534-1-AP) is a rabbit polyclonal antibody that shows reactivity with Human and has been validated for the following applications: IF, IHC, WB,ELISA.
- Reactivity
- Human
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references ATM Inhibition Enhances Knock-in Efficiency by Suppressing AAV-Induced Activation of Apoptotic Pathways.
Peposertib suppresses generation of FLT3-internal tandem duplication formed by contralateral double nicks.
IL-6/KIAA1429 promotes ferroptosis resistance in endometrial cancer through m6A modification of DDIT3.
SMYD2 inhibition-mediated hypomethylation of Ku70 contributes to impaired nonhomologous end joining repair and antitumor immunity.
Natsagdorj ME, Hara H, Uosaki H, Nakahara F, Inoue M, Hanazono Y
Communications biology 2026 Feb 6;9(1):177
Communications biology 2026 Feb 6;9(1):177
Peposertib suppresses generation of FLT3-internal tandem duplication formed by contralateral double nicks.
Yoshida S, Onozawa M, Yokoyama S, Matsukawa T, Goto H, Hirabayashi S, Kondo T, Hashimoto D, Onodera Y, Teshima T
Experimental hematology 2025 Sep;149:104819
Experimental hematology 2025 Sep;149:104819
IL-6/KIAA1429 promotes ferroptosis resistance in endometrial cancer through m6A modification of DDIT3.
Shen X, Shu W, Zhang J, Zhou T, Dong K, Zhang J, Yao Y, Li H, Cheng S, Zhang T, Chen G, Yu S, Zhang Q, Wang H, Liu Y
Cellular signalling 2025 Oct;134:111906
Cellular signalling 2025 Oct;134:111906
SMYD2 inhibition-mediated hypomethylation of Ku70 contributes to impaired nonhomologous end joining repair and antitumor immunity.
Tang M, Chen G, Tu B, Hu Z, Huang Y, DuFort CC, Wan X, Mao Z, Liu Y, Zhu WG, Lu W
Science advances 2023 Jun 16;9(24):eade6624
Science advances 2023 Jun 16;9(24):eade6624
No comments: Submit comment
No validations: Submit validation data